Data in humans support a role for greater autophagy in ATGL-deficient muscles; biopsies from patients with neutral lipid storage disease with myopathy have more vacuoles that are positive for autophagy markers LC3, p62, and Beclin-1 (41). Here, MAP1LC3A is linked to Lipid storage disease.